Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-13

Clinical Trial Update: Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effectiveness of the Typhoid Vi Vaccine against typhoid and paratyphoid fever in Hechi, Guangxi, China; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Typhoid Vi Vaccine (Vi polysaccharide vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Typhoid, Paratyphoid Fever | Phase 4 | Status: COMPLETED